Appen Limited (ASX:APX) Reports 16% Revenue Growth and Outlines 2025 Strategy
Appen Limited (ASX:APX) reports 16% revenue growth in 2024 and outlines strategic plans for sustainable growth in 2025.
The Hub of Australian Finance News
Appen Limited (ASX:APX) reports 16% revenue growth in 2024 and outlines strategic plans for sustainable growth in 2025.
Simble Solutions Limited (ASX:SIS) reports significant 2024 operational achievements and strategic partnerships, driving growth and expansion.
Hastings Technology Metals (ASX:HAS) forms a 60:40 joint venture with Wyloo for the Yangibana Project, advancing development and reducing costs.
Tempest Minerals Limited (ASX:TEM) reports excellent initial metallurgical results for the Remorse Deposit at Yalgoo Project.
HITIQ Limited (ASX:HIQ) launches a non-renounceable entitlement issue aiming to raise up to $2.92 million to expand manufacturing and USA operations.
Chimeric Therapeutics (ASX:CHM) reports that two of three patients achieved complete response in its ADVENT-AML Phase 1B clinical trial.
IAG (ASX:IAG) enters a $1.35 billion strategic alliance with RAC to expand insurance services in Western Australia.
Ava Risk Group (ASX:AVA) secures a A$1.1 million contract with Honeywell to deploy its sensing technology in Abu Dhabi’s oil and gas field.
Tamboran Resources Corporation (ASX:TBN) announces 3Q FY25 results, highlighting successful well completions and financial milestones.
Bass Oil Limited (ASX:BAS) announces a rights issue and strategic acquisitions to accelerate growth and unlock long-term value for investors.